Tariffs, consolidation and a string of supplier disruptions have defined the past few months for hospital supply chain leaders. Here are four forces shaping their work heading into 2027.
1. Tariff pressure on medical supplies. The Trump administration left PPE and medical supplies off its U.S.-China tariff reduction list. That keeps cost pressure on some of hospitals’ highest-volume purchases.
2. A push to make more supplies domestically. BD struck a $19 billion agreement with the federal government to expand U.S. production. It plans to add about 5 billion medical consumables a year and make all needles it sells in the U.S. domestically. In exchange, BD gets relief from future Section 232 tariffs. HHS also plans to publish quarterly PPE demand forecasts to help manufacturers plan production.
3. GPO concentration. Vizient, HealthTrust and Premier served 84.1% of U.S. hospitals in 2024, up from 61.7% in 2014. Supply chain leaders want that scale to deliver more, including fairer pricing for smaller hospitals, clearer rebate accounting and contracts that give resilience as much weight as cost.
4. Cyberattacks on suppliers. Cyberattacks on Stryker in March and Boston Scientific in August halted order processing and shipping for weeks. Hospitals were hit hard even though their own networks were never breached. Supply chain teams have built playbooks for responding when a vendor goes offline.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
